Rosa Morales
Overview
Rosa M. Morales is a counsel in Crowell & Moring’s Antitrust and Competition Group in the firm’s New York office.
Career & Education
- Barnard College, B.A., 2000
- Fordham University School of Law, J.D., 2006
- New York
- U.S. District Court for the Eastern District of New York
- U.S. District Court for the Southern District of New York
- U.S. Court of Appeals for the Federal Circuit
Professional Activities and Memberships
- Member, New York City Bar Association
- Member, American Bar Association, Antitrust, Intellectual Property, and International Law sections
- Board Member, New York City Anti-Violence Project (former)
- Associate Board Member, New York Legal Assistance Group (former)
- Spanish
- French
Rosa's Insights
Client Alert | 3 min read | 04.22.24
In the latest sign that federal enforcers remain focused on increasing antitrust enforcement, last Thursday, the Justice Department (DOJ), Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) revealed an online portal, HealthyCompetition.gov, to encourage the public to submit reports on potential anticompetitive and monopolistic conduct in the healthcare sector. The initiative seeks to address concerns that such behavior may affect healthcare affordability and quality, and employee wages.
Speaking Engagement | 04.10.24
"Do Non-Competes Cause More Harm Than Good?," 72nd Antitrust Law Spring Meeting, Washington, D.C.
Press Coverage | 01.26.24
Top Ten 2024: Antitrust Trends And Forecast For The Health Care Industry
Publication | 01.01.24
Representative Matters
Includes matters handled prior to joining Crowell & Moring.
- Representing third parties in federal and state antitrust investigations related to technology sector.
- Represented certified indirect-purchaser class of premium payers in tying and anti-steering claims against Sutter Health
- Represented over sixty merchants and merchant coalitions in credit- and debit-card swipe fee antitrust action against Visa and MasterCard
- Advised federal district court on damages in reverse-payment antitrust action against branded and generic manufacturers of blockbuster drug
- Defended major Japanese airline against allegations of price-fixing of passenger airfares following Department of Justice investigation
- Defended large French bank against bid-rigging and price-fixing claims in municipal bond market
- Defended premier Canadian food and beverage maker against class action allegations of conspiracy to fix chocolate prices
- Represented international registry operator and global provider of domain name registry services in arbitration involving dispute over rulemaking processes and auction award for new top-level domain
- Represented specialty pharmacy benefit manager in horizontal merger
Rosa's Insights
Client Alert | 3 min read | 04.22.24
In the latest sign that federal enforcers remain focused on increasing antitrust enforcement, last Thursday, the Justice Department (DOJ), Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) revealed an online portal, HealthyCompetition.gov, to encourage the public to submit reports on potential anticompetitive and monopolistic conduct in the healthcare sector. The initiative seeks to address concerns that such behavior may affect healthcare affordability and quality, and employee wages.
Speaking Engagement | 04.10.24
"Do Non-Competes Cause More Harm Than Good?," 72nd Antitrust Law Spring Meeting, Washington, D.C.
Press Coverage | 01.26.24
Top Ten 2024: Antitrust Trends And Forecast For The Health Care Industry
Publication | 01.01.24
Practices
Rosa's Insights
Client Alert | 3 min read | 04.22.24
In the latest sign that federal enforcers remain focused on increasing antitrust enforcement, last Thursday, the Justice Department (DOJ), Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) revealed an online portal, HealthyCompetition.gov, to encourage the public to submit reports on potential anticompetitive and monopolistic conduct in the healthcare sector. The initiative seeks to address concerns that such behavior may affect healthcare affordability and quality, and employee wages.
Speaking Engagement | 04.10.24
"Do Non-Competes Cause More Harm Than Good?," 72nd Antitrust Law Spring Meeting, Washington, D.C.
Press Coverage | 01.26.24
Top Ten 2024: Antitrust Trends And Forecast For The Health Care Industry
Publication | 01.01.24